Metabolic and immunogenetic prediction of long‐term insulin remission in African patients with atypical diabetes
The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Abstract
Aims We aimed to characterize a cohort of ‘atypical’ diabetic patients of sub‐Saharan African origin and to analyse possible determinants of long‐term remission. Methods Over 6 years, we studied the clinical and therapeutic profile of 42 consecutive patients undiagnosed or untreated prior to inclusion presenting with cardinal features of diabetes mellitus. We measured insulin secretion and sensitivity at inclusion. Immunogenetic (anti‐GAD, anti‐ICA and HLA class II) markers of Type 1 diabetes were compared with a 90‐non‐diabetic unrelated adult African population. Results Twenty‐one ketonuric patients (age 42 ± 9 (sd) years; body mass index (BMI) 26 ± 3 kg/m 2) were initially insulin‐treated (IT), and 21 non‐ketonuric patients (age 38 ± 8 years; BMI 26 ± 5 kg/m 2) had oral and/or diet therapy (NIT). Insulin could be discontinued in 47.6% (10/21) IT with adequate glycaemic control (HbA 1c 6.7 ± 1.3%), while insulin was secondarily started in 38.1% (8/21) NIT in expectation of better control. The initial basal (odds ratio (OR) 9.1, 95% confidence interval (CI) 1.3–64.4) and stimulated C‐peptide (OR 8.17, 95% CI 1.5–44.1) were independently associated with remission. Insulin resistance was present in all the groups, more marked in the insulin‐treated NIT. Anti‐GAD antibodies and ICA were rare, but 38.1% IT vs. 1.1% controls had Type 1 diabetes HLA susceptibility haplotypes (P < 0.001) without significant difference between the subgroups. Conclusion Prolonged discontinuation of insulin is frequent in African diabetic patients initially presenting with signs of insulinopenia. In our patients, long‐term insulin therapy was not associated with immunogenetic markers of Type 1 diabetes. The initial measure of insulin secretion seemed a good predictor of long‐term remission.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Banerji, M. A., Chaiken, R. L., Huey, H., Tuomi, T., Norin, A. J., Mackay, I. R., Rowley, M. J., Zimmet, P. Z., & Lebovitz, H. E. (1994) · Diabetes · doi:10.2337/diab.43.6.741 · Cited by 266
Cited by
Ketosis-Prone Type 2 Diabetes in Patients of Sub-Saharan African Origin
Mauvais-Jarvis, F., Sobngwi, E., Porcher, R., Riveline, J.-P., Kevorkian, J.-P., Vaisse, C., Charpentier, G., Guillausseau, P.-J., Vexiau, P., & Gautier, J.-F. (2004) · Diabetes · doi:10.2337/diabetes.53.3.645 · Cited by 294
“We used the C-peptide response to glucagon, which is the best predictor of further remission in ketosis-prone type 2 diabetes (6,9) (Fig.”
BackgroundMethodInfluentialSelf-citationNarrative Review: Ketosis-Prone Type 2 Diabetes Mellitus
Umpierrez, G. E., Smiley, D., & Kitabchi, A. E. (2006) · Annals of Internal Medicine · doi:10.7326/0003-4819-144-5-200603070-00011 · Cited by 299
“Most investigators recommend intravenous glucagon stimulation to assess pancreatic insulin reserve (6, 7, 12, 15, 17).”
BackgroundResultInfluentialDiabetes in Africa: epidemiology, management and healthcare challenges
Levitt, N. S. (2008) · Heart · doi:10.1136/hrt.2008.147306 · Cited by 290
Syndromes of ketosis-prone diabetes mellitus
Balasubramanyam, A., Nalini, R., Hampe, C. S., & Maldonado, M. (2008) · Endocrine Reviews · doi:10.1210/er.2007-0026 · Cited by 200
EADSG Guidelines: Insulin Therapy in Diabetes
Silver, B., Ramaiya, K., Andrew, S. B., Fredrick, O., Bajaj, S., Kalra, S., Charlotte, B. M., Claudine, K., & Makhoba, A. (2018) · Diabetes Therapy · doi:10.1007/s13300-018-0384-6 · Cited by 179
“The period of near-normoglycemic remission may last for a few months to several years [138, 139].”
Background
Metadata
- Authors
- Sobngwi, E., Vexiau, P., Levy, V., Lepage, V., Mauvais‐Jarvis, F., Leblanc, H., Mbanya, J. C., & Gautier, J. F.
- Venue
- Diabetic Medicine
- Publisher
- Wiley
- Published
- 2002-10
- Volume
- 19
- Issue
- 10
- Pages
- 832-835
- ISSN
- 0742-3071 (ISSN-L)
- 1464-5491
- OpenAlex
- W2019243766
- Cited by
- 68
- References
- 1
- FWCI
- 2.00
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Metabolic and immunogenetic prediction of long‐term insulin remission in African patients with atypical diabetes. https://app.cochat.ai/papers/10.1046/j.1464-5491.2002.00802.x
- The paper
- Sobngwi, E., Vexiau, P., Levy, V., Lepage, V., Mauvais‐Jarvis, F., Leblanc, H., Mbanya, J. C., & Gautier, J. F. (2002). Metabolic and immunogenetic prediction of long‐term insulin remission in African patients with atypical diabetes. Diabetic Medicine. https://doi.org/10.1046/j.1464-5491.2002.00802.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.